DAPASUG-10
MRP: 2,100
Packaging: 10x14
Pack Type: tablet
Composition:
Dapagliflozin 10mg
Indication:
Type 2 Diabetes
Description:
Dapagliflozin 10 mg** is an oral antidiabetic medication that belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter-2 inhibitors). It works by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine and thereby lowering blood sugar levels.
Primarily used in the management of Type 2 Diabetes Mellitus, Dapagliflozin not only improves glycemic control but also offers additional benefits such as weight reduction and cardiovascular risk reduction. It may also be prescribed for heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease (CKD) as part of a broader treatment plan.
Tags:
- Effectively lowers blood sugar levels
- Reduces risk of cardiovascular events in diabetics
- Aids in weight management
- Provides kidney protection in diabetic and CKD patients
- Improves outcomes in heart failure patients
Usage Information
Dosage
Recommended Dose: One 10 mg tablet once daily Can be taken with or without food Follow the dose and schedule prescribed by your healthcare provider Do not stop or change dosage without consulting your doctor
Side Effects
Urinary tract infections Genital infections (e.g., yeast infections) Increased urination Dehydration or low blood pressure Rare: Diabetic ketoacidosis, especially in insulin users
Contraindications
Known hypersensitivity to Dapagliflozin Patients with Type 1 Diabetes History of diabetic ketoacidosis Severe renal impairment or end-stage kidney disease Pregnant or breastfeeding women without medical supervision
Availability
Dapagliflozin 10mg tablet SGLT2 inhibitor for diabetes Type 2 diabetes medication Blood sugar lowering tablets Dapagliflozin for heart failure Oral antidiabetic medicine Dapagliflozin weight loss CKD and Dapagliflozin Dapagliflozin 10 mg benefits Glucose reabsorption inhibitor